In contrast, non‐vascular and atypical ulcers demonstrated very low recurrence rates of 4.8% and 6.3%, respectively, further highlighting the effectiveness of PTPG across diverse ulcer etiologies. This evidence concerns the gene PTPRG and ulcer disease.